Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

NCT07165886 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

298

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroenteropancreatic Neuroendocrine Tumors

Interventions

DRUG: Sirolimus for injection (albumin bound)
DRUG: Octreotide long-acting injection
DRUG: Everolimus

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.